Announcements
- Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Lifecore Biomedical Completes Incremental Liquidity Initiatives
- Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
- Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
- Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
- Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
- Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
- Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
- Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
- Lifecore Biomedical Provides Business Update
More ▼
Key statistics
As of last trade, Lifecore Biomedical Inc (LDE:FRA) traded at 5.45, 21.11% above the 52 week low of 4.50 set on Mar 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.45 |
---|---|
High | 5.45 |
Low | 5.45 |
Bid | 5.65 |
Offer | 5.85 |
Previous close | 5.25 |
Average volume | 111.11 |
---|---|
Shares outstanding | 30.55m |
Free float | 28.64m |
P/E (TTM) | -- |
Market cap | 178.39m USD |
EPS (TTM) | -2.12 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 07:02 BST.
More ▼